Aryavan, Meera, Nile, Thyrocare and More Turning Record Date on Nov 28 for Dividend, Bonus & Split

Several listed companies, including Aryavan Enterprise, Meera Industries, Nile Ltd, Thyrocare Technologies, and Unison Metals, will undergo key corporate actions on 28 November 2025, including dividends, a bonus issue, and a stock split. These changes will impact share prices and investor eligibility for benefits.

Aryavan Enterprise Ltd – Interim Dividend

Aryavan Enterprise will trade ex-dividend on November 28. The company has declared an interim dividend of ₹0.50 per share.

Meera Industries Ltd – Interim Dividend

Meera Industries will also turn ex-dividend on the same day. Investors holding the stock before the ex-date will receive an interim dividend of ₹0.50 per share.

Nile Ltd – Interim Dividend

Nile Ltd has announced a higher interim dividend of ₹5 per share. The stock will trade ex-dividend on November 28.

Thyrocare Technologies Ltd – 2:1 Bonus Issue

Thyrocare Technologies will turn ex-bonus on Friday. The company has approved a 2:1 bonus issue, meaning shareholders will receive two bonus shares for every one share held.

Unison Metals Ltd – 1:10 Stock Split

Unison Metals will trade ex-stock split on November 28. The face value of the shares will change from ₹10 to ₹1, increasing the number of shares and improving liquidity.

Why the Ex-Date Matters

The ex-date decides who is eligible for dividends, bonus shares, or stock split benefits.

On this day, the stock price adjusts to reflect the value of the corporate action.

Stocks Turning Ex-Date on 28 November 2025

Read More, Best Paint Stocks in Dec 2025 - Asian Paints, Berger Paints India & More – Net Profit Margin Basis!

Conclusion

On November 28, investors will see important changes across 5 stocks due to dividends, a bonus issue, and a stock split. Holding the shares in their demat account before the ex-date ensures eligibility for these corporate benefits.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.